Table 2.
Outcome domains and assessments in the standard set
| Category and outcome domain | Agreementa | Outcome assessment | Agreementa |
|---|---|---|---|
| OAB symptom severity and burden | |||
| Frequency of OAB symptoms | 92 | Tracked via ICIQ-OAB | 83 |
| Burden of OAB symptoms | 100 | Tracked via ICIQ-OAB | 83 |
| Health-related quality of life | |||
| Physical functioning | 100 | Assessed via the OAB-Q SF | 85 |
| Social impact | 88 | Assessed via the OAB-Q SF | 85 |
| Emotional health | 100 | Assessed via the OAB-Q SF | 85 |
| Interference with desired activities | 75 | Assessed via the OAB-Q SF | 85 |
| Sexual functioning | 73 | Assessed via the ICIQ-FLUTSsex (women) or ICIQ-MLUTSsex (men) | 83 |
| Treatment benefit and tolerance | 82 | My condition (urinary problems, incontinence) has…(greatly improved/improved/not changed/worsened during treatment). The tolerability of my treatment for OAB is…(inadequate, moderate, good, excellent). | 77 |
| Overall satisfaction with treatment | 100 | My overall satisfaction is…(extremely satisfied/very satisfied/satisfied/not satisfied with the treatment). | 77 |
ICIQ International Consultation on Incontinence Questionnaire, OAB overactive bladder, OAB-Q SF symptom bother and health-related quality of life (HRQL) questionnaire, FLUTS Female Sexual Matters associated with Lower Urinary Tract Symptoms, MLUTSsex Male Sexual Matters associated with Lower Urinary Tract Symptoms
aPercentage agreement among survey respondents (voting IN)